Your email has been successfully added to our mailing list.

×
0 8.01346261720099E-05 8.01346261720099E-05 0.000160269252343906 8.01346261720099E-05 0 0.000240403878515916 0.000368619280391109
Stock impact report

Bristol Myers Sees Over $85 Billion of Demand for M&A Bond Sale [BNN Bloomberg (Canada)]

RayzeBio, Inc. (RYZB) 
Company Research Source: BNN Bloomberg
Therapeutics Inc. and RayzeBio Inc., according to people with knowledge of the matter. The company is said to be targeting $13 billion, according to a person familiar with the matter. The transaction, which followed investor calls on Tuesday, is expected to be priced on Wednesday. Citigroup Inc., Bank of America Corp., Wells Fargo & Co. and Mizuho Financial Group are managing the deal. ©2024 Bloomberg L.P. Show less Read more
Impact Snapshot
Event Time:
RYZB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RYZB alerts
Opt-in for
RYZB alerts

from News Quantified
Opt-in for
RYZB alerts

from News Quantified